Patent Baristas

Since the America Invents Act has now passed, a lot of applicants will now qualify for a 75% reduction in certain fees at the US Patent Office.  The Act created a new micro-entity rate.  Now, various fees are due according to the following schedule: 1.  Regular applicants:  You’re a big boy or girl and you […]

Yesterday, Commissioner Robert L. Stoll talked about the Leahy-Smith America Invents Act at the 21st All Ohio Annual Institute on Intellectual Property here in beautiful, downtown Cincinnati, Ohio. While only a cursory review, Stoll went down the highlights of the provisions that need to be understood now. 15% Surcharge The Leahy-Smith America Invents Act (Public Law […]

Like Bieber fever, the itch to mess with the rules for patenting have spread far and wide.  There is currently being considered a Bill to amend Australia’s patent law, which proposes a number of substantial changes. Description of the invention Under the proposed legislation, there will be a requirement that the description must enable the […]

What: American Conference Institute’s Biotech Patents Conference:  Practical Strategies for Prosecuting and Litigating Biotech Patents in a Rapidly Shifting Legal Environment. The biotech industry faces massive, imminent, change with patent reform nearing passage, impending promulgation of biosimilar pathway regulations from the FDA, the continued evolution of case law from the Federal Circuit and an unusually […]

On September 16, 2011, President Barack Obama signed into law the Leahy-Smith America Invents Act.   This Act is touted as the most comprehensive overhaul to our patent system since 1836. The new law is intended to afford more certainty for patent applicants and owners, and provide the USPTO the resources needed to operate efficiently and […]

“The pharmaceutical industry is trashed nightly as being second only to the tobacco industry in the corporations-we-hate-most department.”    ~ Martin Voet In Martin Voet’s book, The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management (third edition), he provides a concise guide to the necessary information so that pharmaceutical executives, managers, regulatory, legal and […]

This morning, President Obama signed the America Invents Act at Thomas Jefferson High School for Science & Technology in Alexandria, Virginia—a school named for the first official to issue U.S. patents.  On stage with President Obama was a bipartisan group of legislators:  Sen. Patrick Leahy (D-VT); Rep. Lamar Smith (R-TX); Rep. Bob Goodlatte (R-VA); Rep. Jim Moran (D-VA); and Rep. […]

Author and inventor John D. Smith doesn’t want you to file a patent application.  Smith, author of the book “Don’t File a Patent!” book (232 pp.) writes: “The patent process is an illusion of protection that takes inventors’ hard earned money and gives them nothing in return.” So, why would I write about NOT filing […]